Search Within

Maud Condomines

  1. "Michel Sadelain"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. GSK Faculty (9)
  4. Hematologic Malignancies Research (9)
  5. Hematologic Malignancies, Division of (9)
  6. Molecular Pharmacology and Chemistry Program Faculty (9)

More Groups

People
  1. Michel Sadelain (9)
  2. Gertrude Gunset (5)
  3. Jason Plotkin (4)
  4. Zeguo Zhao (4)
  5. Christopher Kloss (3)
  6. Reuben Benjamin (3)

More People

Years
  1. 2015 (3)
  2. 2014 (1)
  3. 2013 (2)
  4. 2012 (2)
  5. 2011 (1)
Publications
  1. Molecular Therapy (2)
  2. Cancer Cell (1)
  3. Cancer Research (1)
  4. Cell Stem Cell (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of Immunology (1)

More Publications

Publishers
  1. Nature Publishing Group (3)
  2. Cell Press (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Public Library of Science (1)
  6. The American Association of Immunologists, Inc (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells
    Journal Article

    Zhao, Z.; Condomines, M.; Van Der Stegen, S. J. C.; Perna, F.; Kloss, C. C.; Gunset, G.; Plotkin, J.; Sadelain, M.
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Optimal activation of both CD28 and 4-1BB in CAR-targeted T cells results in enhanced tumor eradication
    Meeting Abstract

    Zhao, Z.; Van Der Stegen, S. J. C.; Condomines, M.; Perna, F.; Gunset, G.; Plotkin, J.; Sadelain, M.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Tumor-targeted human T cells expressing CD28-based chimeric antigen receptors circumvent CTLA-4 inhibition
    Journal Article

    Condomines, M.; Arnason, J.; Benjamin, R.; Gunset, G.; Plotkin, J.; Sadelain, M.
    PLoS ONE (2015)

    Fulltext@MSK | Save
  • Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy
    Meeting Abstract

    Sadelain, M.; Condomines, M.; Zhao, Z.; Brentjens, R. J.; Riviere, I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • 4-1BBL costimulation enables CD4 T cells expressing a CD28/zeta chimeric antigen receptor to eliminate aggressive leukemia
    Meeting Abstract

    Condomines, M.; Zhao, Z.; Wang, X.; Kloss, C.; Davila, M.; Sadelain, M.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
    Journal Article

    Kloss, C. C.; Condomines, M.; Cartellieri, M.; Bachmann, M.; Sadelain, M.
    Nature Biotechnology (2013)

    Fulltext@MSK | Save
  • CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma
    Meeting Abstract

    Benjamin, R.; Condomines, M.; Gunset, G.; Sadelain, M.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Attenuated CTLA-4 inhibition in CD19-targeted T cells expressing a second-generation CD28-based chimeric antigen receptor
    Meeting Abstract

    Condomines, M.; Arnasson, J.; Benjamin, R.; Plotkin, J.; Gunset, G.; Riviere, I.; Sadelain, M.
    Molecular Therapy (2012)

    Fulltext@MSK | Save
  • Tolerance induction by allogeneic hematopoietic stem cells
    Journal Article

    Condomines, M.; Sadelain, M.
    Cell Stem Cell (2011)

    Fulltext@MSK | Save